Expression and topography of integrins and basement membrane proteins in epidermal carcinomas: Basal but not squamous cell carcinomas display loss of α6β4 and BM-600/nicein

Paola Savoia, Livio Trusolino, Eugenio Pepino, Ottavio Cremona, Pier Carlo Marchisio

Research output: Contribution to journalArticle

Abstract

The expression and topography of some integrins and basement membrane proteins in cutaneous basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) have been studied by immunohistochemistry and Western blotting. It has been shown that the typical cell-to-cell distribution of α2β1 and α3β1 found in normal epidermis is replaced by pericellular distribution in both BCC and SCC cells. BCC and SCC also showed different patterns of expression of α6β4, an integrin heterodimer normally lining the basal surface of basal epidermal keratinocytes: whereas SCC showed high expression and pericellular distribution of α6β4, BCC cells did not express this integrin at all. The absence of α6 and β4 subunits from BCC extracts was confirmed by Western blotting. The molecular composition of the basement membrane was markedly different in the two types of epidermal tumors. Whereas laminin and collagen type IV were conserved in the basement membrane zone of both tumors, the molecular complex BM-600/nicein, which is recognized by the monoclonal antibody GB3 and is possibly identical to the previously described basement membrane glycoproteins kalinin and epiligrin, was absent from BCC cells. Then, the simultaneous loss of expression of α6β4 and BM-600/nicein in BCC cells but not in SCC cells indicates that α6β4 integrin and one of its potential ligands may be co-regulated in both BCC and SCC, thus suggesting a role for this phenomenon in the pathogenesis and clinical behavior of these epidermal tumors.

Original languageEnglish
Pages (from-to)352-358
Number of pages7
JournalJournal of Investigative Dermatology
Volume101
Issue number3
Publication statusPublished - Sep 1993

Fingerprint

Basal Cell Carcinoma
Basement Membrane
Integrins
Topography
Squamous Cell Carcinoma
Membrane Proteins
Carcinoma
Tumors
Collagen Type IV
Western Blotting
Membrane Glycoproteins
Laminin
Linings
Neoplasms
kalinin
Epithelial Cells
Cell Extracts
Keratinocytes
Monoclonal Antibodies
Cells

Keywords

  • squamous cell carcinoma/basal cell carcinoma/integrins/basement membrane proteins

ASJC Scopus subject areas

  • Dermatology

Cite this

@article{e4b39287e4a545a484d35b30adf29fc5,
title = "Expression and topography of integrins and basement membrane proteins in epidermal carcinomas: Basal but not squamous cell carcinomas display loss of α6β4 and BM-600/nicein",
abstract = "The expression and topography of some integrins and basement membrane proteins in cutaneous basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) have been studied by immunohistochemistry and Western blotting. It has been shown that the typical cell-to-cell distribution of α2β1 and α3β1 found in normal epidermis is replaced by pericellular distribution in both BCC and SCC cells. BCC and SCC also showed different patterns of expression of α6β4, an integrin heterodimer normally lining the basal surface of basal epidermal keratinocytes: whereas SCC showed high expression and pericellular distribution of α6β4, BCC cells did not express this integrin at all. The absence of α6 and β4 subunits from BCC extracts was confirmed by Western blotting. The molecular composition of the basement membrane was markedly different in the two types of epidermal tumors. Whereas laminin and collagen type IV were conserved in the basement membrane zone of both tumors, the molecular complex BM-600/nicein, which is recognized by the monoclonal antibody GB3 and is possibly identical to the previously described basement membrane glycoproteins kalinin and epiligrin, was absent from BCC cells. Then, the simultaneous loss of expression of α6β4 and BM-600/nicein in BCC cells but not in SCC cells indicates that α6β4 integrin and one of its potential ligands may be co-regulated in both BCC and SCC, thus suggesting a role for this phenomenon in the pathogenesis and clinical behavior of these epidermal tumors.",
keywords = "squamous cell carcinoma/basal cell carcinoma/integrins/basement membrane proteins",
author = "Paola Savoia and Livio Trusolino and Eugenio Pepino and Ottavio Cremona and Marchisio, {Pier Carlo}",
year = "1993",
month = "9",
language = "English",
volume = "101",
pages = "352--358",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Expression and topography of integrins and basement membrane proteins in epidermal carcinomas

T2 - Basal but not squamous cell carcinomas display loss of α6β4 and BM-600/nicein

AU - Savoia, Paola

AU - Trusolino, Livio

AU - Pepino, Eugenio

AU - Cremona, Ottavio

AU - Marchisio, Pier Carlo

PY - 1993/9

Y1 - 1993/9

N2 - The expression and topography of some integrins and basement membrane proteins in cutaneous basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) have been studied by immunohistochemistry and Western blotting. It has been shown that the typical cell-to-cell distribution of α2β1 and α3β1 found in normal epidermis is replaced by pericellular distribution in both BCC and SCC cells. BCC and SCC also showed different patterns of expression of α6β4, an integrin heterodimer normally lining the basal surface of basal epidermal keratinocytes: whereas SCC showed high expression and pericellular distribution of α6β4, BCC cells did not express this integrin at all. The absence of α6 and β4 subunits from BCC extracts was confirmed by Western blotting. The molecular composition of the basement membrane was markedly different in the two types of epidermal tumors. Whereas laminin and collagen type IV were conserved in the basement membrane zone of both tumors, the molecular complex BM-600/nicein, which is recognized by the monoclonal antibody GB3 and is possibly identical to the previously described basement membrane glycoproteins kalinin and epiligrin, was absent from BCC cells. Then, the simultaneous loss of expression of α6β4 and BM-600/nicein in BCC cells but not in SCC cells indicates that α6β4 integrin and one of its potential ligands may be co-regulated in both BCC and SCC, thus suggesting a role for this phenomenon in the pathogenesis and clinical behavior of these epidermal tumors.

AB - The expression and topography of some integrins and basement membrane proteins in cutaneous basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) have been studied by immunohistochemistry and Western blotting. It has been shown that the typical cell-to-cell distribution of α2β1 and α3β1 found in normal epidermis is replaced by pericellular distribution in both BCC and SCC cells. BCC and SCC also showed different patterns of expression of α6β4, an integrin heterodimer normally lining the basal surface of basal epidermal keratinocytes: whereas SCC showed high expression and pericellular distribution of α6β4, BCC cells did not express this integrin at all. The absence of α6 and β4 subunits from BCC extracts was confirmed by Western blotting. The molecular composition of the basement membrane was markedly different in the two types of epidermal tumors. Whereas laminin and collagen type IV were conserved in the basement membrane zone of both tumors, the molecular complex BM-600/nicein, which is recognized by the monoclonal antibody GB3 and is possibly identical to the previously described basement membrane glycoproteins kalinin and epiligrin, was absent from BCC cells. Then, the simultaneous loss of expression of α6β4 and BM-600/nicein in BCC cells but not in SCC cells indicates that α6β4 integrin and one of its potential ligands may be co-regulated in both BCC and SCC, thus suggesting a role for this phenomenon in the pathogenesis and clinical behavior of these epidermal tumors.

KW - squamous cell carcinoma/basal cell carcinoma/integrins/basement membrane proteins

UR - http://www.scopus.com/inward/record.url?scp=0027202061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027202061&partnerID=8YFLogxK

M3 - Article

C2 - 8370973

AN - SCOPUS:0027202061

VL - 101

SP - 352

EP - 358

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 3

ER -